Haemonetics | HAE - 負債

株価
57.28
毎日の変更
0.99 1.76%
毎月
-6.36%
毎年
-17.42%
Q2 予測
55.16




負債 変化する 日付
Avanos Medical USD 129.1M 4.6M 2025-12
Baxter International USD 9.78B 68M 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Cerus USD 84.16M 791K 2024-12
Cooper Companies USD 2.51B 27M 2025-09
Fresenius EUR 11.93B 919M 2025-12
Fresenius Medical Care EUR 11.03B 233.8M 2026-03
Globus Medical USD 118.66M 687K 2025-12
Haemonetics USD 1.22B 5K 2025-12
ICU Medical USD 1.28B 79.88M 2025-12
Intuitive Surgical USD 0 0 2025-03
Masimo USD 485.9M 100.3M 2026-03
Medtronic USD 28.07B 1.03B 2025-12
Merit Medical Systems USD 821.57M 420K 2025-12
Neogen USD 792.93M 396K 2025-09
OraSure Technologies USD 782K 465K 2024-06
Plus Therapeutics USD 3.98M 372K 2023-12
Quidel USD 2.83B 9.9M 2025-12
ResMed USD 847.72M 1.37M 2025-12
STAAR Surgical USD 38.35M 764K 2025-12
Steris USD 2.05B 4.8M 2025-12
Stryker USD 14.22B 635M 2026-03
Surmodics USD 29.55M 111K 2024-09
Teleflex USD 2.73B 43.5M 2025-12
Terumo JPY 159.87B 14.97B 2025-09
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
US Physical Therapy USD 204.84M 42.38M 2026-03
Zimmer Biomet Holdings USD 7.47B 48.1M 2026-03